0001209191-22-060689.txt : 20221212 0001209191-22-060689.hdr.sgml : 20221212 20221212162525 ACCESSION NUMBER: 0001209191-22-060689 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221208 FILED AS OF DATE: 20221212 DATE AS OF CHANGE: 20221212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tak Paul Peter CENTRAL INDEX KEY: 0001873905 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40629 FILM NUMBER: 221457401 MAIL ADDRESS: STREET 1: CANDEL THERAPEUTICS, INC. STREET 2: 117 KENDRICK ST SUITE 450 CITY: NEEDHAM STATE: MA ZIP: 02494 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Candel Therapeutics, Inc. CENTRAL INDEX KEY: 0001841387 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 522214851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 117 KENDRICK STREET STREET 2: SUITE 450 CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 617-916-5445 MAIL ADDRESS: STREET 1: 117 KENDRICK STREET STREET 2: SUITE 450 CITY: NEEDHAM STATE: MA ZIP: 02494 FORMER COMPANY: FORMER CONFORMED NAME: Candel Therapeutics, Inic. DATE OF NAME CHANGE: 20210120 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-12-08 0 0001841387 Candel Therapeutics, Inc. CADL 0001873905 Tak Paul Peter C/O CANDEL THERAPEUTICS, INC. 117 KENDRICK ST., SUITE 450 NEEDHAM MA 02494 1 1 0 0 Chief Executive Officer Common Stock 2022-12-08 2022-12-08 4 P 0 3050 1.70 A 28050 D Common Stock 2022-12-09 2022-12-09 4 P 0 12935 1.92 A 40985 D The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.80. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.89 to $2.00. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Jason A. Amello, as Attorney-in-Fact for Paul Peter Tak 2022-12-12